Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | BLM | P54132 | 1/20 | 0.38 |
| ▸ | WRN | Q14191 | 1/20 | 0.38 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.38 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.34 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.34 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.34 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.34 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.34 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.34 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | MGLL | Q99685 | 3/20 | 0.33 |
| ▸ | ATM | Q13315 | 1/20 | 0.32 |
| ▸ | PSMB8 | P28062 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17756748 | 1.00 | ALDH1A1 (0.38) | ALDH1A1CYP1A2HPGDCYP2C19BLM | |
| SCHEMBL30474637 | 1.00 | ALDH1A1 (0.38) | ALDH1A1CYP1A2HPGDCYP2C19BLM | |
| Ethylene Glycol SCHEMBL1593589 | 0.94 | ALDH1A1 (0.35) | ALDH1A1CYP1A2HPGDCYP2C19BLM | |
| Ethylene Glycol SCHEMBL4555859 | 0.94 | ALDH1A1 (0.35) | ALDH1A1CYP1A2HPGDCYP2C19BLM | |
| Sulfuric Acid SCHEMBL28284052 | 0.92 | MGLL (0.34) | ALDH1A1CYP1A2HPGDCYP2C19BLM | |
| Acetonitrile SCHEMBL27805140 | 0.91 | ALDH1A1 (0.33) | ALDH1A1CYP1A2HPGDCYP2C19BLM | |
| Propionic Acid SCHEMBL28906123 | 0.89 | FFAR3 (0.34) | ALDH1A1CYP1A2HPGDCYP2C19BLM | |
| SCHEMBL7926166 | 0.87 | ALDH1A1 (0.33) | ALDH1A1CYP1A2HPGDCYP2C19BLM | |
| SCHEMBL2738364 | 0.87 | ALDH1A1 (0.41) | ALDH1A1CYP1A2HPGDCYP2C19BLM | |
| SCHEMBL17756764 | 0.87 | ALDH1A1 (0.33) | ALDH1A1CYP1A2HPGDCYP2C19BLM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 7943 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3689898-B1 | LONG-ACTING CONJUGATE OF GLUCAGON-LIKE PEPTIDE-2 (GLP-2) DERIVATIVE | HANMI PHARMACEUTICAL CO LTD (KR) | 2026-04-29 | — | — | EP | claimed |
| EP-4716755-A1 | RNA PROBING AND AMPLIFICATION METHODS FOR SINGLE CELL ANALYSIS ON FIXED CELLS | Becton, Dickinson and Company (US) | 2026-04-01 | — | — | EP | claimed |
| US-12508298-B2 | Protein complex by use of a specific site of an immunoglobulin fragment for linkage | HANMI PHARM. CO., LTD. (KR) | 2025-12-30 | — | — | US | claimed |
| EP-4667566-A1 | ARGININE DEIMINASE MUTANT, COVALENT DIMER AND CONJUGATE AND USE THEREOF | Peg-Bio Biopharm Co., Ltd. (Chongqing) (CN) | 2025-12-24 | — | — | EP | claimed |
| US-20250295792-A1 | POLYETHYLENE GLYCOL-MODIFIED FORM OF KININ OR DERIVATIVE THEREOF AND PHARMACEUTICAL USE THEREOF | ZONHON BIOPHARMA INSTITUTE, INC. (CN) | 2025-09-25 | — | — | US | claimed |
| EP-4608872-A2 | SIZE-TUNABLE SYNTHETIC PARTICLES WITH TUNABLE OPTICAL PROPERTIES AND METHODS FOR USING THE SAME FOR IMMUNE CELL ACTIVATION | Slingshot Biosciences, Inc. (US) | 2025-09-03 | — | — | EP | claimed |
| US-20250270275-A1 | PHARMACEUTICAL COMPOSITION COMPRISING POLYPEPTIDE | D&D PHARMATECH INC. (KR) | 2025-08-28 | — | — | US | claimed |
| US-20250222078-A1 | MODIFIED HYALURONIDASES AND USES IN TREATING HYALURONAN-ASSOCIATED DISEASES AND CONDITIONS | HALOZYME, INC. (US) | 2025-07-10 | — | — | US | claimed |
| EP-4580694-A1 | SEALANTS FOR TISSUE CLOSURE | Ethicon, Inc. (US) | 2025-07-09 | — | — | EP | claimed |
| EP-4582090-A2 | COMPOSITION COMPRISING PEGYLATED ARGININE DEIMINASE | Polaris Group (TW) | 2025-07-09 | — | — | EP | claimed |
| WO-1998039464-A2 | ADENOVIRUS VECTORS CONTAINING HETEROLOGOUS TRANSCRIPTION REGULATORY ELEMENTS AND METHODS OF USING SAME | CELL GENESYS, INC. (US) | 1998-09-11 | — | — | WO | claimed |
| WO-1998039467-A2 | ADENOVIRUS VECTORS SPECIFIC FOR CELLS EXPRESSING CARCINOEMBRYONIC ANTIGEN AND METHODS OF USE THEREOF | CALYDON, INC. (US) | 1998-09-11 | — | — | WO | claimed |
| WO-1998039466-A2 | ADENOVIRUS VECTORS SPECIFIC FOR CELLS EXPRESSING ANDROGEN RECEPTOR AND METHODS OF USE THEREOF | CALYDON, INC. (US) | 1998-09-11 | — | — | WO | claimed |
| WO-1998039465-A2 | ADENOVIRUS VECTORS SPECIFIC FOR CELLS EXPRESSING ALPHA-FETOPROTEIN AND METHODS OF USE THEREOF | CELL GENESYS, INC. (US) | 1998-09-11 | — | — | WO | claimed |
| WO-1998031383-A1 | MODIFIED TUMOR NECROSIS FACTOR | PHOENIX PHARMACOLOGICS, INC. (US) | 1998-07-23 | — | — | WO | claimed |
| WO-1997043645-A1 | ANTIBODIES DIRECTED AGAINST DITHIOCARBAMATES | MEDINOX, INC. (US) | 1997-11-20 | — | — | WO | claimed |
| CN-1126441-A | Amplification of vitamin B12 absorption System Using polymers | BIOTECH AUSTRALIA PTY LTD (AU) | 1996-07-10 | — | — | CN | claimed |
| CN-1101780-A | Method and means for preventing secondary cataract | PHARMACIA AB (SE) | 1995-04-19 | — | — | CN | claimed |
| US-4959309-A | Fast photochemical method of labelling nucleic acids for detection purposes in hybridization assays | MOLECULAR DIAGNOSTICS, INC. (US) | 1990-09-25 | — | — | US | claimed |
| US-4166820-A | Selenium compounds | SPALLHOLZ JULIAN E | 1979-09-04 | — | — | US | claimed |